Global Acetaminophen Market to Reach USD 15.2 Billion by 2033 at a 4.2% of CAGR

Global Acetaminophen Market
Global Acetaminophen Market

The global acetaminophen market is on track for substantial growth, with a valuation of USD 9.8 billion at the end of 2022. According to a recent study by Future Market Insights, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 4.2%, reaching approximately USD 15.2 billion by 2033.

Acetaminophen, a widely used analgesic and antipyretic, continues to dominate the over-the-counter medication landscape. The study reveals that the oral route of administration leads the market, capturing around 92.4% of the global market share in 2022. This preference highlights the effectiveness and convenience of oral acetaminophen in managing pain and fever.

Get your PDF – Sample Report

Global Health Issues:

The field of pain management is intricately linked to worldwide health issues, particularly the profound effects of cancer. Given that 19.3 million people would be impacted by cancer globally in 2020, the National Cancer Institute’s finding that 20% to 50% of cancer patients experience pain highlights how important efficient analgesics are. The aging population is expected to add 21.7 million more cancer cases globally by 2030, increasing the need for trustworthy pain management treatments.

After-Opioid Epidemic Transition:

In the aftermath of the USA opioid epidemic, nations worldwide are recalibrating their approach to opioid prescribing. Governments in industrialized nations are championing the adoption of non-opioid analgesics, presenting a unique opportunity for businesses to pioneer cutting-edge non-opioid medications.

Key Takeaways:

  • Based on product type, the acetaminophen segment is projected to growt at a 4.1% CAGR through 2031.
  • The oral route of administration segment accounted for 92.4% of the total market share in 2021.
  • In terms of sales type, the OTC (over the counter) segment accounted for 91.6% of the global market share in 2021.
  • Sales through retail pharmacies will continue gaining traction. In 2021, the segment accounted for 28.5% of the total market share.
  • North America held the largest share of 33.0% of the global acetaminophen market in 2021, and the trend is expected to continue over the assessment period.

“Growing demand for self-aid and cost-effective OTC pain relievers, along with increasing usage of acetaminophen as the first line of treatment for pain management are the key factors projected to drive the market in the forthcoming years,” says the FMI analyst.

Competition Landscape:

Leading players operating in the global acetaminophen market are Abbott, Janssen Pharmaceuticals, Inc. [Johnson & Johnson], Bristol-Myers Squibb and Company, Cardinal Health Inc., Viatris, Procter & Gamble Company, Sanofi, Novartis AG, Bayer AG, Teva Pharmaceutical Industries Ltd, Perrigo Company, Mallinckrodt Pharmaceuticals, Glaxo SmithKline Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, and Sun Pharmaceutical Industries Ltd.

Some of the leading companies of the acetaminophen market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence. For instance:

  • Johnson & Johnson, In March 2020,  announced that it will be boosting up production of its flagship product Tylenol which is an over-the-counter pain killer
  • GlaxoSmithKline, In February 2020 was approval by the Food and Drug Administration for Advil Dual Action, with acetaminophen as an over-the-counter (OTC) product for pain relief.

Customization Available – Here

Key Companies Profiled:

  • Pfizer Inc.
  • Sanofi
  • Janssen Pharmaceuticals.
  • Bayer AG
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb and Company
  • Teva Pharmaceutical Industries Ltd
  • Cardinal Health Inc.
  • Perrigo Company.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Abbott
  • Mallinckrodt Pharmaceuticals
  • Procter & Gamble Company

Key Market Segments Covered in Acetaminophen Drugs Industry Research:

By Product:

  • Acetaminophen
  • Acetaminophen with Opioids
  • Others

By Route of Administration:

  • Oral
  • Injectable
  • Others

By Sales:

  • OTC (Over-the-counter)
  • Rx (Prescription)

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-commerce
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

In-Depth Market Overview – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Enteral Feeding Devices Market Expected to Reach USD 4.1 Billion by 2033 at a 4.0% of CAGR

Enteral Feeding Devices
Global Enteral Feeding Devices Market

The global enteral feeding devices market is projected to experience steady growth over the next decade. Valued at USD 2.8 billion in 2023, the market is anticipated to expand at an average Compound Annual Growth Rate (CAGR) of 4.0%, reaching approximately USD 4.1 billion by 2033.

Enteral feeding devices, which are critical for delivering nutrition to patients who cannot consume food orally, are increasingly in demand due to the rising prevalence of chronic diseases, an aging population, and the growing need for home healthcare solutions. The market’s steady growth is supported by advancements in medical technology and increasing awareness about the benefits of enteral nutrition.

Get your PDF – Sample Report

The promising future of the enteral feeding device market highlights its vital function in the healthcare industry in providing for the nutritional requirements of patients unable to swallow food. With consistent expansion and ongoing innovation, the industry is poised to significantly advance patient care across the globe.

Key Takeaways:

  • Market Growth: The enteral feeding devices market is projected to grow at a CAGR of 4.0% from 2023 to 2033.
  • Current and Future Valuation: The market holds a current valuation of US$ 2.8 billion in 2023 and is expected to reach US$ 4.1 billion by 2033.
  • Driving Factors: Key drivers of this growth include rising incidences of chronic diseases, technological advancements in medical devices, and an aging global population necessitating increased nutritional support.
  • Market Dynamics: The market dynamics are influenced by healthcare providers’ increasing focus on homecare settings, enhancing patient comfort and reducing hospital stays.

Enteral Feeding Devices Market — Regional Analysis

  • North America and Europe are expected to cumulatively account for nearly 70% of overall market value, with the former holding 40% of the share.
  • The dominance of these regions is attributed to favorable medical policies and the strong presence of market players.
  • Asia Pacific is forecasted to register tremendous growth on the back of rising healthcare expenditure, the presence of a large patient pool, and a burgeoning number of preterm births.

Enteral Feeding Devices Market — Competitive Landscape

Major market players operating in the market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company, and Dynarex Corporation among others. Market players are focusing on developing innovative products with low weight to increase portability.

On these lines, Infinity Feeding Pumps launched the Zevex EnteraLite Infinity Feeding Pump, which weighs less than one pound.

Customization Available – Here

Key Contributors:

  • Abbott Nutrition
  • ALCOR Scientific
  • Applied Medical Technology
  • B. Braun Melsungen AG
  • Boston Scientific
  • CONMED Corporation
  • Cook Medical
  • Cardinal Health, Inc.
  • Becton, Dickinson, and Company
  • Fresenius Kabi
  • Owens & Minor, Inc. (Halyard Health)
  • Medline
  • Moog
  • Nestlé Health Science
  • Danone SA
  • Vygon SA
  • Amsino International, Inc.
  • Fuji Systems Corp
  • Neomed
  • Smiths Medical (Smiths Group)

Key Segments:

By Product Type:

  • Enteral Feeding Pumps
  • Nasogastric Tubes
  • Nasojejunal Tubes
  • Percutaneous Endoscopic Gastrostomy (PEG) Kit
    • PEG Balloon Kit
    • PEG Non-Balloon Kit
  • Replacement G-Tubes
    • Replacement Balloon G-Tubes
    • Replacement Non-Balloon G-Tubes
  • Percutaneous Endoscopic Gastro-Jejunostomy (PEGJ) Tubes
  • Low-profile Tubes
    • Low-profile Balloon Tubes
    • Low-profile Non-Balloon Tubes

By Age Group:

  • Adult
  • Pediatric

By End User:

  • Hospital
  • Clinic
  • Ambulatory Surgical Center
  • Home Care Setting

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • The Middle East & Africa (MEA)

Explore In-Depth Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Canine Atopic Dermatitis Treatment Market to Reach USD 1,620.50 Million by 2034 at a 7.6% of CAGR

Canine Atopic Dermatitis Treatment Market
Global Canine Atopic Dermatitis Treatment Market

The global canine atopic dermatitis treatment market is poised for steady growth over the next decade. Valued at USD 1,182.60 million in 2024, the market is expected to expand to approximately USD 1,620.50 million by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 3.2% from 2024 to 2034. This marks a significant decrease from the previous CAGR of 7.6% observed between 2019 and 2023.

The updated market report highlights the evolving dynamics in the canine atopic dermatitis treatment sector. While the growth rate has moderated, the market continues to benefit from the rising prevalence of atopic dermatitis in dogs and the increasing demand for effective treatment options. Advances in veterinary medicine and greater awareness among pet owners are contributing to sustained market demand.

Request Your Detailed Report – Sample With Your Work Email

Key Takeaways of Canine Atopic Dermatitis Treatment Market Study

  • Immunosuppressant drugs that currently lead the market will lose their market share to monoclonal antibodies (mAb).
  • Oral administration remains at the forefront of preferred drug intake method.
  • Injectable drugs will witness a steady CAGR and will rise to prominence by 2029, surpassing oral administration.
  • Retail pharmacies continue to hold the leading revenue share; veterinary clinics closing in.
  • Gains in canine atopic dermatitis treatment market are concentrated in North America.

Top Growth Drivers

  • Established players in human life sciences are investing significant pecuniary resources in veterinary science, ascertaining the market growth.
  • Robust healthcare infrastructure and rising pet ownership are bolstering the growth of market in North America.
  • Swift recovery and less side effects remain the growth levers fueling demand for injectable veterinary drugs.
  • Increasing online availability and easy accessibility of medical information will continue to be the significant growth contributor.

Key Restraints

  • Certain therapeutic agents are facing increasing resistance, which is limiting the demand for immunosuppressant drugs.
  • Ineffectual management by healthcare providers is a major hindrance to market growth.

Unlock Tailored Insights – Customize Your Report for Maximum Impact

Competitive Landscape

Leading players in global canine atopic dermatitis treatment market include, but are not limited to, Elanco Animal Health, Zoetis, Boragen Inc., and Immunomic Therapeutics Inc. Industry giants are focused on strategic alliances with regional players to boost their global presence. They continue to direct substantial resources towards regional acquisitions in order to fortify their market foothold. For instance, Zoetis acquired Nexvet Biopharma (2018) to accelerate the development of mAb therapies. This would enable the company to create new alternatives for treating canine atopic dermatitis. On the other hand, Elanco Animal Health acquired Boehringer Ingelheim Vetmedica, Inc. (2017), to innovate their range of rabies vaccines, canine and feline products.

Canine Atopic Dermatitis Treatment Market By Category

By Drug Class :

  • Corticosteroids
  • Immunosuppressants
  • Antibiotics
  • Antihistamines
  • Emollients
  • Essential Fatty Acids
  • Antipruritics
  • Monoclonal Antibodies

By Route of Administration :

  • Topical
  • Oral
  • Injectable

By Distribution Channel :

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies

Obtain In-Depth Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Dosimetry Market Set to Reach USD 4,882.60 Million by 2034 at a 4.5% of CAGR

Dosimetry Market
Global Dosimetry Market

According to a recently updated edition of the dosimetry market report by Future Market Insights (FMI), the global dosimetry market is poised for significant growth over the next decade. Valued at USD 3,144.10 million in 2024, the market is projected to expand at an average growth rate of 4.5%, reaching approximately USD 4,882.60 million by 2034.

The market’s robust growth is driven by the rising prevalence of conditions such as cardiovascular diseases (CVD), cancer, and neurology-related disorders, which are increasing the demand for dosimeters. Dosimetry, the measurement, calculation, and assessment of ionizing radiation doses, plays a critical role in ensuring accurate and safe radiation exposure for patients undergoing various medical treatments.

To capture a larger share of this expanding market, industry players are focusing on enhancing their product offerings and improving service delivery. This strategic emphasis on innovation and quality is expected to drive further market growth and meet the evolving needs of healthcare providers and patients.

Get your PDF – Sample Report

Key Takeaways:

  • Market Valuation: The global dosimetry market was valued at US$3,144.10 million in 2024, with a projected growth to US$4,882.60 million by 2034, reflecting an average growth rate of 4.5%.
  • Rising Disease Prevalence: Increasing incidences of cardiovascular diseases, cancer, and neurology-related disorders are driving the demand for dosimeters, emphasizing the importance of radiation safety and monitoring in healthcare and other industries.
  • Market Expansion: The dosimetry market continues to expand as players enhance their product offerings and elevate service delivery to cater to the growing demand for radiation safety solutions in diverse sectors.
  • Innovation and Product Enhancement: Industry players are focusing on innovation and product enhancement to gain a greater share in the growing dosimetry market, offering advanced dosimeters with improved features and capabilities.
  • Role in Radiation Safety: Dosimeters play a critical role in radiation safety by providing real-time monitoring and actionable insights to mitigate health risks associated with radiation exposure, ensuring occupational safety and regulatory compliance.

Customization Available –  Here

Acquisition Key Strategy Followed by Leading Manufacturers:

Leading manufacturers in the Dosimetry market are focusing on the acquisition strategy to enhance their product portfolio and expand their regional presence.  For instance, in 2017, Fortive acquired Landauer, a leading global provider of subscription-based technical and analytical services to determine occupational and environmental radiation exposure.

In 2016, Mirion Technologies Inc. acquired Canberra Industries. Mirion’s acquisition of Canberra brings together two of the most respected and experienced industry players, and offers comprehensive and compelling solutions for the global customer base.

Major Players are:

  1. Honeywell
  2. Fisher Scientific Inc.
  3. Landauer, Inc. (Fortive)
  4. Mirion Technologies Inc.
  5. Fuji Electric Corporation of America
  6. Polimaster Inc.
  7. JP Laboratories Inc

Want more insights on the Dosimetry market?

A new study by Future Market Insights opines on the evolution of the Dosimetry market from 2014 to 2021, and presents demand projections for 2022 to 2029, on the basis of product (personal electronic dosimeters, self-reading dosimeters, processed dosimeters), modality (wearable and non-wearable), energy (active dosimeters and passive dosimeters), and end user (industrial, medical, oil and gas, defence, homeland security, mining, environmental, others), across seven prominent regions.

Dosimetry Market by Category

By Product Type:

  • Personal Electronic Dosimeter
  • Self-reading Dosimeters
  • Processed Dosimeters

By Modality:

  • Wearable
    • Collar level
    • Chest level
    • Waist level
    • Wrist level
    • Finger level
  • Non-wearable

By Energy:

  • Active Dosimeters
  • Passive Dosimeters
    • Optically Stimulated Luminescence Dosimeter (OSLD)
    • Thermoluminescence Dosimeters (TLD)
    • Radiophotoluminescence (RPL)

By End User:

  • Industrial
  • Medical
  • Oil and Gas
  • Defense, Homeland Security
  • Mining
  • Environmental
  • Others

Get Full Market Analysis Now – Purchase The Report

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Mucosal Atomization Device Market to Reach USD 1.11 Billion by 2034 at a 6.9% of CAGR

Mucosal Atomization Devices Market
Global Mucosal Atomization Devices Market

The global mucosal atomization device market is projected to experience steady growth over the next decade. With an estimated market value of USD 570.52 million in 2024, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 6.9%, reaching approximately USD 1.11 billion by 2034.

Mucosal atomization devices are gaining traction due to their ability to deliver medications quickly and efficiently through the mucous membranes. This method of administration is increasingly preferred in various medical applications, including emergency medicine, pain management, and vaccinations, due to its non-invasive nature and rapid onset of action.

Get your PDF – Sample Report

Developed regional markets ought to hold a substantial portion of the market in terms of value. Furthermore, a noteworthy development rate is projected for the Asia Pacific market. Because of advancements in medical technology, it is projected that North America will account for the greatest revenue shares in mucosal atomization devices for the foreseeable future. Anticipations of a high rate of drug delivery device adoption in the region are driving the mucosal atomization device market in Europe. On the other hand, the market in Asia Pacific is projected to rise at a significant pace since new, useful medical devices are being introduced more frequently.

The market for mucosal atomization devices: vendor insights

The study features a number of well-known industry participants who have made names for themselves as industry leaders in the mucosal atomization device market. Medica Holdings, LLC, Kurve Technology, Cook Medical Incorporated, DeVilbiss Healthcare LLC, and Teleflex Incorporated are a few prominent companies in the global mucosal atomization devices market. In the market for mucosal atomization devices, there are only few major players.

The development of novel and highly advanced mucosal atomization devices is the primary focus of key players. Important participants are also engaged in partnerships and acquisitions, which may spur the market for mucosal atomization devices to expand.

Customization Available – Here

Mucosal Atomization Devices Market: Overview

The global market for Mucosal Atomization Devices is expected to witness high growth over the forecast period as the technology does not require the set up for intravenous drug delivery. The target is achieved at a much higher rate. The drug gets directly into the bloodstream and to the target area however one has to be very sure of the dosage as it can cause side effects if over dosed. The market of treatment of mucosal atomization devices is expected to increase with a rise in the patient pool as the treatment is target specific.

Mucosal Atomization Devices Market: Regional Outlook

Geographically, the global mucosal atomization devices market can be segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be a dominant market in the global mucosal atomization devices market, owing to the high prevalence of diseases. Also, the market in North America will rise, due to advancements in technology and strict regulations pertaining to patient care and safety in the region. The mucosal atomization devices market in Asia Pacific excluding Japan is expected to grow with a significant CAGR due to expansion of product offering by key players. In addition, government is making initiatives in the region by providing better healthcare facilities with techniques which require less pain and more efficiency and contribute to the growth of the Mucosal Atomization Devices. Europe is expected to hold the second largest share in the global mucosal atomization devices market throughout the forecast period.

Mucosal Atomization Devices Market: Key Players

The global market for mucosal atomization devices market is highly consolidated. Examples of some of the key players operating in the global mucosal atomization devices market DS Medical,  Life-Assist, Inc., Teleflex Medical Europe Ltd, MedTree, Kurve Technology and Wolfetory Medical Inc.among others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Explore Full Market Analysis Now – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug of Abuse Testing Market Projected to Reach USD 2.69 Billion by 2033 at a 5.3% of CAGR

Drug of Abuse Testing
Global Drug of Abuse Testing Market

The global drug of abuse testing market is poised for notable growth over the next decade. Estimated to capture a valuation of USD 1.65 billion in 2023, the market is projected to expand at a Compound Annual Growth Rate (CAGR) of 5.3%, reaching approximately USD 2.69 billion by 2033.

This growth is primarily driven by the increasing demand for rapid and accurate drug testing equipment across various sectors, including forensic laboratories, hospitals, and senior citizen care centers. The rising prevalence of drug abuse and the need for efficient diagnostic tools are further fueling the market expansion.

Get your PDF – Sample Report

Key Takeaways:

  • The drug abuse testing market is estimated to secure a valuation of US$ 2.69 billion in 2033 with a CAGR of 5.3% during the forecast period.
  • In the historical period, the market secured a valuation of US$ 1.5 billion in 2022.
  • The United States dominates the global market by capturing a maximum share of 25.5% during the forecast period.
  • Germany is significantly driving the global market by registering a share of 4% by 2033.
  • With a share of 3.3%, Japan is securing a significant share in the global market during the forecast period.

How are Key Players Adding Value in the Global Market?

Several prominent players consolidates the market presence globally. These players are developing innovative products by adopting advanced technologies. They offer improved and high-quality products to their consumers as per their needs.

Key players are adopting various marketing methodologies to elevate the global market. These marketing methodologies are partnerships, mergers, acquisitions, collaborations, product launches, and agreements. The key players are conveniently provided delivery of their products and services through their distribution networks.

They are marketing and promoting their products in social media, online retailers, and offline platforms to increase their sales volume. These players are significantly expanding the market by providing awareness and educating their customers at trade shows, exhibitions, and seminars.

Customization Available – Here

Competitive Landscape:

The top 5 players operating in the global market comprise Quest Diagnostics, Roche Holding AG, Siemens AG (Siemens Healthineers), and Thermo Fisher Scientific, Inc., the top players accounting for maximum sales in the market.

Leading players operating in the global drug of abuse testing market are focusing on research and development to launch novel testing tools that are more effective and accurate. Players also invest in mergers, acquisitions, collaborations, and partnerships to expand their global footprint.

Other Essential Players in the Global Market are:

  • Quest Diagnostics
  • Roche Holding AG
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Abbott Laboratories (Alere, Inc.)
  • Shimadzu Corporation
  • Express Diagnostics International Inc.
  • Drägerwerk AG & Co. KGaA
  • Laboratory Corporation of America Holdings.

Drug of Abuse Testing Market by Category

By Drug Type:

  • Psychostimulants
  • Narcotic
  • Cannabinoids
  • Sedatives
  • Others

By Technique:

  • Immunoassay
  • Chromatography
  • Rapid Testing

By End User:

  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

In-Depth Market Overview – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Intra-Abdominal Pressure Measurement Devices Market to Reach USD 318.3 Million by 2033 at a 12.4% of CAGR

Intra-Abdominal Pressure Measurement Devices
Global Intra-Abdominal Pressure Measurement Devices Market

The global  intra-abdominal pressure measurement devices market is set for substantial growth, with an expected valuation of USD 98.9 million in 2023. The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 12.4% over the forecast period, reaching approximately USD 318.3 million by 2033.

This growth is driven by the increasing prevalence of intra-abdominal hypertension and abdominal compartment syndrome. These conditions are fueling the demand for effective and accurate intra-abdominal pressure measurement devices, which are essential for timely diagnosis and management.

Get your PDF – Sample Report

Improved Patient Safety and Demographic Shifts Drive Demand

The ability to monitor abdominal pressure effectively translates to improved patient safety by offering healthcare providers the means to prevent complications and enhance treatment outcomes. As a result, hospitals and clinics are increasingly investing in these devices to minimize risks and improve patient care.

The growing geriatric population and the rising incidence of chronic diseases such as chronic kidney disease, diabetes, cardiovascular issues, and obesity are further contributing to market growth. These demographics require close monitoring, and intra-abdominal pressure measurement devices provide a valuable tool for managing such conditions.

Key Takeaways:

  • The intra-abdominal pressure measurement devices market is estimated to secure a valuation of US$ 328.3 million with a CAGR of 12.40% by 2033.
  • In the historical period, the market captured a valuation of US$ 89.4 million with a CAGR of 10.6% in 2022.
  • The United States dominates the global market by registering a share of 45.1% during the forecast period.
  • Japan is anticipated to secure a share of 6.4% in the global market by 2033.
  • With a CAGR of 15.70%, Australia is significantly driving the global market by 2033.
  • Germany is another nation predicted to register a share of 6.7% in the global market during the forecast period.

Customization Available – Here

Competitive Landscape:

The market is highly fragmented, with several competitors in the intra-abdominal pressure measurement devices space. These companies are implementing mergers and acquisitions, partnerships and collaborations, and new product launches to meet consumer demand and expand their customer base.

Other Prominent Players in the Global Market are:

  • R. Bard, Inc.
  • ConvaTec Group PLC
  • Stryker Corporation
  • Biometrix Ltd. (Degania Silicone, Ltd.)
  • Centurion Medical Products
  • Holtech Medical
  • ConvaTec Group PLC
  • Potrero Medical
  • Gaeltec Devises Ltd.
  • Speigelberg GmbH & Co. KG.
  • C2Dx Inc.
  • Scranton Gillette Communication
  • Nutrimedics S.A.
  • SEM Mthembu Medical (Pty) Ltd
  • Carl Zeiss AG

Market by Category:

By Product:

  • Disposables
  • Equipment

By Application:

  • Intra-abdominal Hypertension
  • Intra-compartment Pressure

By End User:

  • Hospitals
  • Clinics
  • Trauma Centers
  • Ambulatory Surgical Centers (ASCs)

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

In-Depth Market Analysis: – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Obesity Management Market Set to Reach USD 3,494.5 Million by 2033 at a 5.2% of CAGR

Weight Loss and Obesity Management Industry
Global Obesity Management Market

The global obesity management market is anticipated to experience significant growth over the next decade, with a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period from 2023 to 2033. The market, valued at USD 2,095.6 million in 2023, is projected to expand to USD 3,494.5 million by 2033.

This growth is driven by increasing awareness of obesity-related health risks, advancements in obesity management treatments, and a rising global prevalence of obesity. As healthcare providers and patients seek effective solutions to combat obesity, the demand for comprehensive obesity management strategies continues to rise.

Get your PDF  – Sample Report

Future Outlook for a Pressing Challenge

As the battle against obesity continues, the obesity management market is well-positioned for sustained growth in the coming years. Addressing this global health challenge will require continued innovation and accessibility within the market to ensure effective solutions reach those who need them most.

Businesses that have understood the benefits of integrating obesity management services into their employee wellness programs are also contributing to the market’s growth. Growing awareness and focus on preventative healthcare is encouraging people to get expert assistance in managing their weight and overall health. Additionally, industrialized places where obesity and other lifestyle-related disorders have become major public health concerns exhibit this tendency.

Many customers are unable to receive professional treatment or participate in weight-management programs because of the stigma attached to obesity and cultural prejudices. Additionally, some people may be deterred from using obesity control programs and therapies by their high cost, particularly in low-income areas or emerging nations.

Key Takeaways from the Global Obesity Management Market Study Report by FMI

  • The United States is the leading market in the adoption of obesity management strategies and generated around 32.1% of the global revenue share in 2022. Moreover, market players in the United States are making continuous investments in research and development, working with healthcare practitioners, and taking a patient-centric approach.
  • Germany is the leading market in the Europe region which had a global market share of 29.5% in the year 2022.
  • It is anticipated that demand for obesity management services and solutions in the Asia Pacific region could witness a high CAGR through 2033. For instance, China and India are poised to witness 6.6% and 6.4% CAGRs over the next ten years.

Unlock Tailored Insights – Customize Your Report for Maximum Impact

Competitive Landscape for the Obesity Management Market Players

The complexity of obesity and the lack of a universally applicable management strategy are two key barriers even for these leading market players. It is difficult to provide solutions that are universally beneficial since each individual may require a treatment plan that is specialized and unique to them.

In recent years the growing percentage of obese people in third-world countries has encouraged many start-ups to adopt the business of obesity management. However, for such emerging players, it could be essential to make sure obesity control treatments are affordable and accessible to increase their impact.

Key Players Profiled in the Global Market:

  • GlaxoSmithKline Plc.
  • VIVUS, Inc.
  • Novo Nordisk A/S
  • Currax Pharmaceuticals LLC
  • Cheplapharm Arzneimittel GmbH
  • Bausch Health Companies Inc.
  • Takeda Pharmaceuticals, Inc.

Key Segmentation

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East & Africa (MEA)
  • Europe

Unlock In-Depth Market Insights – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Painkillers Market Projected to Reach USD 100.9 Billion by 2033 at a 3.7% of CAGR

Painkillers Market
Global Painkillers Market

The global painkillers market is poised for steady growth, with an estimated valuation of USD 70.0 billion by the end of 2023. According to a recent study by Future Market Insights, the market is expected to expand at a Compound Annual Growth Rate (CAGR) of 3.7%, reaching approximately USD 100.9 billion by 2033.

In 2022, opioids dominated the painkillers market, accounting for approximately 53.4% of the global market share. This significant share highlights the continued reliance on opioids for pain management despite growing concerns about addiction and the push for alternative pain relief methods.

Get your PDF – Sample Report 

In the end, developing non-opioid extended-release medications is essential to addressing the opioid issue and providing patients with a safer option. Consequently, this development will drive the painkiller market as a whole throughout the estimated period of 2023 to 2033.

Key Takeaways:

  • The global painkiller market is estimated at US$70.0 billion in 2023 and is projected to reach US$100.9 billion by 2033, reflecting a steady CAGR of 3.7%.
  • Opioids currently dominate the market, holding a share of approximately 53.4% in 2022. However, the market is expected to see a rise in demand for alternative pain management solutions.

Competitive Landscape:

Key market players in the painkillers market launch their products. This promotional strategy is expected to be highly impactful to enter into the market.

A few of the recent instances include

  • In March 2023, Perrigo Company plc received final approval for its Abbreviated New Drug Application from the “FDA” for ibuprofen Tablets and acetaminophen, 250 mg/125 mg.
  • In January 2023, Procter & Gamble (P&G) India added new Vicks ZzzQuil NATURA to its existing portfolio of Vicks in India.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the Painkillers market, which are available in the full report.

Key Companies Profiled:

  • AbbVie Inc. (Allergan plc)
  • Bristol Myers Squibb Co.
  • Sanofi S.A.
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  • GSK plc.
  • Abbott Laboratories, Inc.
  • Novartis AG
  • Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Ltd.
  • Mallinckrodt Pharmaceuticals
  • Endo Pharmaceuticals Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Procter & Gamble
  • AstraZeneca
  • Cardinal Health
  • Perrigo Company Plc.
  • Bausch Health Companies Inc.
  • Viatris
  • Amneal Pharmaceuticals
  • Purdue Pharmaceuticals L.P.

Key Market Segments Covered in Painkillers Industry Research:

By Drug Class:

  • Opioids
    • Tramadol
    • Oxycodone
    • Hydrocodone
    • Other Opioids
  • NSAIDs
  • Local Anesthetics
  • Acetaminophen

By Product:

  • OTC Products
  • Prescription Drugs

By Indication:

  • Surgical Pain
  • Cancer Pain
  • Neuropathic Pain
  • Musculoskeletal and Joint Pain
  • Others

By Route of Administration:

  • Injectable
  • Oral
  • Rectal
  • Topical
  • Transdermal
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Specialty Clinics
  • Long Term Care Centers
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East and Africa

In-Depth Market Overview – Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Non-Invasive Pulse Wave Tonometer Market Valued at USD 194 Million in 2032 at a 5.8% of CAGR

Non-Invasive Pulse Wave Tonometer
Global Non-Invasive Pulse Wave Tonometer Market

The global non-invasive pulse wave tonometer market is anticipated to achieve a valuation of USD 104.3 million in 2022. This market growth is driven by the crucial role of proper blood flow in maintaining overall health and reducing the risk of heart and other blood flow-related issues.

The non-invasive pulse wave tonometer is a very good device that can help to understand the flow pattern and provide the information so that the proper treatment can be provided. The overall demand for non-invasive pulse wave tonometersis projected to grow at a CAGR of 5.8% between 2022 and 2032, totaling around USD 194 Million by 2032.

Non-invasive pulse wave tonometers are essential tools for measuring blood pressure and assessing arterial health without the need for invasive procedures. As blood flows from the heart through various veins and arteries, maintaining its proper circulation is vital for transporting nutrients and drugs throughout the body, ensuring optimal health and function.

Get your PDF – Sample Report

The ability of non-invasive pulse wave tonometers to offer precise, real-time data on blood flow and vascular health without intrusive treatments is what is driving the increased demand for these devices. The use of this technology is growing in significance as people and healthcare professionals look for approaches that are least invasive and highly successful.

Key Takeaways:

  • Market Valuation: The non-invasive pulse wave tonometer market is projected to reach a valuation of US$ 104.3 million in 2022.
  • Health Benefits: Proper blood flow is vital for maintaining health and reducing risks associated with cardiovascular conditions and other blood flow-related problems.
  • Technology Impact: Pulse wave tonometry provides a non-invasive method for monitoring and assessing blood flow, aiding in the early detection and management of potential health issues.
  • Nutrient and Drug Delivery: Efficient blood flow ensures the effective transportation of nutrients and medications to various parts of the body, emphasizing the importance of circulatory health.

The burgeoning market for non-invasive pulse wave tonometers reflects a growing recognition of the importance of circulatory health in preventing and managing a range of medical conditions. As technology advances, the capabilities of pulse wave tonometry are expected to expand, offering even greater benefits for health monitoring and management.

Unlock Tailored Insights: Customize Your Report for Maximum Impact

Key players :

  • ADInstruments
  • Millar
  • DiaTecne s.r.l
  • AtCor Medical Pty. Ltd.
  • Haag Streit AG
  • Ametek Industries Technology
  • Ray Vision International Corporation
  • Crystalvue Medical
  • Shanghai Vowish Optical Co. Ltd

Key Segments Covered in the Non-invasive Pulse Wave Tonometer Industry Analysis:

Non-invasive Pulse Wave Tonometer Market: Segmentation

Valuable information covered in the FMI’s Non-invasive Pulse Wave Tonometer market report has been segregated into key segments and sub-segments.

Non-invasive Pulse Wave Tonometer Market by End User:

  • Non-invasive Pulse Wave Tonometers for Hospitals
  • Non-invasive Pulse Wave Tonometers for Clinics
  • Non-invasive Pulse Wave Tonometers for Other End Users

Non-invasive Pulse Wave Tonometer Market by Indication:

  • Non-invasive Pulse Wave Tonometers for Hypertension
  • Non-invasive Pulse Wave Tonometers for Renal Disease
  • Non-invasive Pulse Wave Tonometers for COPD
  • Non-invasive Pulse Wave Tonometers for Diabetes
  • Non-invasive Pulse Wave Tonometers for Heart Failure
  • Non-invasive Pulse Wave Tonometers for Other Disease Indications

Non-invasive Pulse Wave Tonometer Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Non-invasive Pulse Wave Tonometer market. Competitive information detailed in the Non-invasive Pulse Wave Tonometer market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Non-invasive Pulse Wave Tonometer market report.

Unlock Comprehensive Market Overview: Purchase Now to Access

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube